GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Benazepril Hydrochloride

Company
Baylor Research Institute
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Benazepril Hydrochloride and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00000620

    Action to Control Cardiovascular Risk in Diabetes (ACCORD)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sites
    Cardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary Disease
    View official trial listing →
  • Completed NCT NCT00136773

    Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus

    Not yet reported Novartis 332 participants Est. completion 2005-11
    Other conditions: Albuminuria
    View official trial listing →
  • Completed NCT NCT00136851

    Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

    Not yet reported Novartis Pharmaceuticals 259 participants Est. completion 2005-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00139555

    Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension

    Not yet reported Novartis 125 participants Est. completion 2006-11 1 site
    Other conditions: Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Terminated NCT NCT00170950

    Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension

    Not yet reported Novartis 11506 participants Est. completion 2008-05 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00171119

    A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

    Not yet reported Novartis Pharmaceuticals 81 participants 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171366

    A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.

    Not yet reported Novartis 1422 participants Est. completion 2005-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00185120

    Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

    Not yet reported Daiichi Sankyo 152 participants Est. completion 2006-09 20 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00234871

    Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

    Not yet reported Abbott 357 participants
    Other conditions: Hypertension, Diabetes, Proteinuria
    View official trial listing →
  • Terminated NCT NCT00270426

    Benazepril for Advanced Chronic Renal Insufficiency

    Not yet reported Southern Medical University, China
    Other conditions: Chronic Kidney Failure
    View official trial listing →
  • Completed NCT NCT00309257

    Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

    Not yet reported Mario Negri Institute for Pharmacological Research 9 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Alport Syndrome
    View official trial listing →
  • Terminated NCT NCT00338091

    Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency

    Not yet reported Southern Medical University, China Est. completion 2006-05 1 site
    Other conditions: Renal Insufficiency,Chronic, Disease Progression, Proteinuria, Dose-Response Relationship,Drug, ACE Inhibitor, Angiotensin II Type 1 Receptor Blockers
    View official trial listing →
  • Completed NCT NCT00367094

    Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

    Not yet reported Novartis 296 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00367978

    Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus

    Not yet reported Novartis 275 participants Est. completion 2003-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00494715

    Preventing ESRD in Overt Nephropathy of Type 2 Diabetes

    Not yet reported Mario Negri Institute for Pharmacological Research 102 participants Est. completion 2016-04 15 sites Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00503152

    Preventing Microalbuminuria in Type 2 Diabetes

    Not yet reported Mario Negri Institute for Pharmacological Research 612 participants Est. completion 2016-09 9 sites Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT00630708

    Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency

    Not yet reported Nanfang Hospital, Southern Medical University 309 participants Est. completion 2014-03 1 site
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT00649038

    Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 24 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649402

    Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

    Not yet reported Mylan Pharmaceuticals Inc 64 participants Est. completion 2004-06 1 site Stand-alone
    Other conditions: Healhty
    View official trial listing →
  • Completed NCT NCT00649519

    Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mg

    Not yet reported Mylan Pharmaceuticals Inc 54 participants Est. completion 2004-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649597

    Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

    Not yet reported Mylan Pharmaceuticals Inc 56 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00664846

    Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

    Not yet reported Peking Union Medical College Hospital 4000 participants Est. completion 2011-04 46 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00691314

    Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis

    Not yet reported Peking Union Medical College Hospital 300 participants Est. completion 2010-12 10 sites Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack, Atherosclerosis, Stenosis, Stents
    View official trial listing →
  • Completed NCT NCT00721773

    Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

    Not yet reported Sun Yat-sen University 200 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Renal Function Disorder
    View official trial listing →
  • Completed NCT NCT00778674

    Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 30 participants Est. completion 2004-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00778726

    Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 42 participants Est. completion 2004-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00834977

    Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 48 participants Est. completion 2004-05 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00835367

    Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions

    Not yet reported Teva Pharmaceuticals USA 68 participants Est. completion 2004-03 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00836537

    Benazepril HCl 40 mg Tablets, Fed

    Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2001-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00836576

    Benazepril HCl 40 mg Tablets, Fasting

    Not yet reported Teva Pharmaceuticals USA 40 participants Est. completion 2001-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00907374

    Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria

    Not yet reported Charles Drew University of Medicine and Science 46 participants Est. completion 2009-04 1 site Stand-alone
    Other conditions: Microalbuminuria
    View official trial listing →
  • Completed NCT NCT01095939

    Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia

    Not yet reported University Hospital, Geneva 120 participants Est. completion 2018-03 2 sites Stand-alone
    Other conditions: Renal Alteration
    View official trial listing →
  • Completed NCT NCT01155895

    Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 54 participants Est. completion 2004-04 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01155908

    Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 48 participants Est. completion 2005-05 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01234922

    Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

    Not yet reported Wake Forest University Health Sciences 6 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Hypertension, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01375322

    ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

    Not yet reported TSH Biopharm Corporation Limited 226 participants Est. completion 2010-06 4 sites Stand-alone
    Type 2 diabetes Other conditions: Hypertension, Albuminuria
    View official trial listing →
  • Completed NCT NCT01505998

    Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 49 participants Est. completion 2007-05 1 site Stand-alone
    Other conditions: Fed
    View official trial listing →
  • Completed NCT NCT01506011

    Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 50 participants Est. completion 2007-04 1 site Stand-alone
    Other conditions: Fasting
    View official trial listing →
  • Completed NCT NCT01603940

    Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

    Not yet reported Hospital Universitario Pedro Ernesto 30 participants Est. completion 2015-01 1 site
    Other conditions: Hypertension, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01669434

    Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

    Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site
    Other conditions: Hypotension on Induction
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01867047

    ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

    Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone
    Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
    View official trial listing →
  • Completed NCT NCT01917149

    Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy

    Not yet reported Xijing Hospital 480 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Status unknown NCT NCT02532777

    The Research of Standard Diagnosis and Treatment for HSPN in Children

    Not yet reported Nanjing Children's Hospital 100 participants Est. completion 2020-07 1 site
    Other conditions: Henoch-Schoenlein Purpura Nephritis
    View official trial listing →
  • Status unknown NCT NCT02532790

    The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children

    Not yet reported Nanjing Children's Hospital 100 participants Est. completion 2020-07 1 site Stand-alone
    Other conditions: Henoch-Schoenlein Purpura Nephritis
    View official trial listing →
  • Status unknown NCT NCT03591471

    Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment

    Not yet reported, Not yet reported Henan University of Traditional Chinese Medicine 500 participants Est. completion 2018-12 2 sites
    Other conditions: Henoch-Schönlein Purpura Nephritis
    View official trial listing →
  • Completed NCT NCT03682692

    ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)

    Not yet reported Shanghai Jiao Tong University School of Medicine 560 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Active, not recruiting NCT NCT04486118

    Centrally Acting ACE Inhibition in SLE

    Not yet reported Northwell Health 36 participants Est. completion 2026-03-01 7 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT04937907

    Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

    Not yet reported Shanghai Children's Hospital 50 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Alport Syndrome, X-Linked
    View official trial listing →
  • Status unknown NCT NCT05670028

    Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization

    Not yet reported Beijing Tiantan Hospital 100 participants Est. completion 2026-06-04 Stand-alone
    Cardiovascular disease Other conditions: Revascularization, Blood Pressure, Cerebrovascular Insufficiency, Cerebral Autoregulation, Individuation
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07486453

    Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 60 participants Est. completion 2026-04-25 1 site Stand-alone
    Other conditions: Primary Hypertension
    View official trial listing →
  • Enrolling by invitation NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Benazepril Hydrochloride, Lotensin, Lotensin HCT, Benazepril

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.